Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001American Medical AssociationThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This issue of MMWR focuses on injection drug use and highlights ways that state and local health departments monitor injection drug use-related health issues and develop interventions to prevent substance abuse and infections among injection drug users (IDUs). Substance abuse and addiction are major underlying causes of preventable morbidity and mortality in the United States.1 The risks increase when illicit substances are injected, which contributes to multiple health and social problems for IDUs, including transmission of bloodborne infections (e.g., human immunodeficiency virus [HIV] and hepatitis B and C infections) through sharing unsterile drug injection equipment and practicing unsafe sex.2 In the United States, approximately one third of acquired immunodeficiency syndrome cases3 and one half of new hepatitis C cases4 are associated with injection drug use. Fatal drug overdoses also contribute to death among IDUs.5 Although the number of persons who inject illicit drugs (primarily heroin, cocaine, and amphetamine) is not available, approximately one million persons in the United States are active IDUs.6
Public Health and Injection Drug Use. JAMA. 2001;285(21):2706. doi:10.1001/jama.285.21.2706